Rubric Capital Management (New York)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-719,809
| Closed | -$16.7M | – | 79 |
|
|
2023
Q1 | $16.7M | Hold |
719,809
| – | – | 0.43% | 47 |
|
|
2022
Q4 | $18.9M | Sell |
719,809
-229,357
| -24% | -$6.01M | 0.82% | 37 |
|
|
2022
Q3 | $18.7M | Hold |
949,166
| – | – | 0.94% | 34 |
|
|
2022
Q2 | $16.6M | Buy |
949,166
+384,813
| +68% | +$6.73M | 0.87% | 36 |
|
|
2022
Q1 | $9.23M | Hold |
564,353
| – | – | 0.33% | 47 |
|
|
2021
Q4 | $9.21M | Hold |
564,353
| – | – | 0.44% | 48 |
|
|
2021
Q3 | $7.2M | Buy |
564,353
+238,490
| +73% | +$3.04M | 0.2% | 44 |
|
|
2021
Q2 | $4.6M | Hold |
325,863
| – | – | 0.29% | 49 |
|
|
2021
Q1 | $5.06M | Hold |
325,863
| – | – | 0.3% | 53 |
|
|
2020
Q4 | $5.17M | Sell |
325,863
-1
| -0% | -$16 | 0.38% | 48 |
|
|
2020
Q3 | $3.96M | Hold |
325,864
| – | – | 0.37% | 52 |
|
|
2020
Q2 | $3.76M | Buy |
325,864
+151,644
| +87% | +$1.75M | 0.43% | 46 |
|
|
2020
Q1 | $2.39M | Buy |
+174,220
| New | +$2.39M | 0.38% | 44 |
|